Department of Cardiac Surgery, Children’s Hospital Boston, Boston, MA 02115, USA.
Cell Transplant. 2011;20(4):515-22. doi: 10.3727/096368910X532729. Epub 2010 Sep 30.
Umbilical cord blood (UCB) is recognized as an enriched source of endothelial progenitor cells (EPCs) with potential therapeutic value. Because cryopreservation is the only reliable method for long-term storage of UCB cells, the clinical application of EPCs depends on our ability to acquire them from cryopreserved samples; however, the feasibility of doing so remains unclear. In this study we demonstrate that EPCs can be isolated from cryopreserved UCB-derived mononuclear cells (MNCs). The number of outgrowth EPC colonies that emerged in culture from cryopreserved samples was similar to that obtained from fresh UCB. Furthermore, EPCs obtained from cryopreserved MNCs were phenotypically and functionally indistinguishable from freshly isolated ones, including the ability to form blood vessels in vivo. Our results eliminate the necessity of performing cell isolation procedures ahead of future clinical needs and suggest that EPCs derived from cryopreserved UCB may be suitable for EPC-related therapies.
脐带血(UCB)被认为是富含内皮祖细胞(EPCs)的丰富来源,具有潜在的治疗价值。由于冷冻保存是 UCB 细胞长期储存的唯一可靠方法,因此 EPC 的临床应用取决于我们从冷冻保存样本中获取它们的能力;然而,这样做的可行性仍不清楚。在这项研究中,我们证明可以从冷冻保存的 UCB 衍生单核细胞(MNC)中分离出 EPC。从冷冻保存样本中培养出的体外 EPC 集落的数量与从新鲜 UCB 中获得的数量相似。此外,从冷冻保存的 MNC 中获得的 EPC 在表型和功能上与新鲜分离的 EPC 没有区别,包括在体内形成血管的能力。我们的结果消除了在未来临床需求之前进行细胞分离程序的必要性,并表明源自冷冻保存的 UCB 的 EPC 可能适合 EPC 相关治疗。